Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy

Actas Urologicas Espanolas

Volumn 34, Issue 1, 2010, Pages 63-70

  Huguet, J ^a   Gaya, J M ^a   Sabate S ^a   Palou, J ^a   Villavicencio, H ^a  

^a FUNDACIÓ PUIGVERT   (Spain)

Author keywords

BCG; Bladder cancer; Cystectomy

Indexed keywords

BCG VACCINE;

AGED; ARTICLE; BIOPSY; BLADDER TUMOR; CANCER INVASION; CYSTECTOMY; DISEASE COURSE; DRUG RESISTANCE; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; URETHRA;

EID: 77952107298     PISSN: 13863006     EISSN: None     Source Type: Journal    
DOI: 10.1016/s2173-5786(10)70011-1     Document Type: Article

References (25)

1. V. Pasandoro P. Emiliozzi F. De Paula P. Scarpone A. Pasandoro C.N. Sternberg Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience Eur Urol 59 2002 227 231
2. J.W. Davis S.I. Sheth J. Doviak P.F. Schellhammer Superficial bladder carcinoma treated with bacillus Calmette-Guérin: progression-free and disease specific survival with minimum 10-year follow-up J Urol 167 2002 494 505
3. R.J. Silvester A.P.M. van der Meijden D.L. Lamm Intravesical bacillus Calmette-Guérin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
4. M.S. Cookson H. Herr Z. Zhang S. Soloway P.C. Sogani W.R. Fair The treated natural history of high risk superficial bladder cancer: 15-year outcome J Urol 158 1997 62 67
5. M. Babjuk W. Oosterling R. Sylvester E. Kaasinen A. Böhle J. Palou-Redorta European Association of Urology (EAU) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2 2008 303 314
6. H.W. Herr P.C. Sogany Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166 2001 1296 1299
7. J. Huguet M. Crego S. Sabate J. Salvador J. Palou H. Villavicencio Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor Eur Urol 48 2005 53 59
8. H.W. Herr S.M. Donat Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome J Urol 161 1999 1854
9. E. Solsona I. Iborra J. Rubio J. Casanova S. Almenar The optimum timing of radical cystectomy for patrients with recurrent high-risk superficial bledder tumor BJU Int 94 2004 125
10. A. López-Beltran P. Bassi M. Pavone-Macaluso R. Montironi Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter and renal pelvis Eur Urol 45 2004 257 266
11. J.A. Witges Management of BCG failures in superficial bladder cancer: a review Eur Urol 49 2006 790 797
12. A.M. Nieder M.A. Simon S.S. Kim M. Manoharan M. Soloway Radical cystectomy after bacillus Calmette-Guérin for high risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation Urology 67 2006 737 741
13. F.J. Bianco D. Justa D.J. Grignon W.A. Sakr J.E. Pontes D.P. Wood Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy Urol Oncol 22 2004 290 294
14. B.P. Schrier M.P. Hollander B.W. van Rhijn L.A.L.M. Kiemeney J.A. Witges Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumors and implications for therapy Eur Urol 45 2004 292 296
15. D. Turkolmez H. Tokgoz B. Resorlu K. Kose Y. Beduk Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors Urology 70 2007 478 481
16. M. May C. Helke T. Nitzke H. Vogler B. Hoschke Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation Urol Int 72 2004 103 111
17. S.P. Lerner C.M. Tangen H. Sucharew D. Wood D. Crawford Paterns of recurrence and outcomes following induction bacillus Calmette-Guérin for high risk Ta, T1 bladder cancer J Urol 177 2007 1727 1731
18. G.V. Raj H. Herr A.M. Serio S.M. Donat B.H. Bochner A.J. Vickers Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer J Urol 177 2007 1283 1286
19. A. Gupta Y. Lotar P.J. Bastian G.S. Palapattu P.I. Karakiewicz G.V. Raj Outcomes of patients with clinical T1 grade urothelial cell bladder carcinoma treated with radical cystectomy Urology 71 2008 302 307
20. S.C. Dutta J.A. Smith S.B. Shappell C.S. Coffey S.S. Chang M.S. Cookson Clinical under staging of high risk nonmuscle invasive urotelial carcinoma treated with radical cystectomy J Urol 166 2001 490 493
21. M.C. Hall S.S. Chang G. Dalbagni R.S. Pruthi J.D. Seigne E.C. Skinner Guideline for the management of non-muscle invasive bladder cancer (stages Ta, T1, Tis): 2007 update J Urol 178 2007 2314 2330
22. E. Pieras J. Palou L. Rodríguez-Villamil F. Millán J. Salvador J. Vicente Cystoscopic follow up of initial T1 G3 bladder tumors treated with BCG Arch Esp Urol 54 2001 211 217
23. A. Orsola J. Palou B. Xabier F. Algaba J. Salvador J. Vicente Primary bladder carcinoma in situ: assessment of early response as a prognostic factor Eur Urol 33 5 1998 457 463
24. S. Denzinguet H.-M. Fritsche W. Otto A. Blana W.F. Wieland M. Burger Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol 53 2008 146 152
25. J. Palou F. Algaba I. Vera O. Rodríguez H. Villavicencio M. Sánchez-Carbayo Protein expression patterns of Ezrin are predictors of progression in T1 G3 bladder tumors treated with nonmaitenance bacillus Calmette-Guerin Eur Urol 56 2009 829 836